These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200 [TBL] [Abstract][Full Text] [Related]
3. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria. Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073 [TBL] [Abstract][Full Text] [Related]
4. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400 [TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. Amura CR; Kamei T; Ito N; Soares MJ; Morrison DC J Immunol; 1998 Sep; 161(5):2552-60. PubMed ID: 9725255 [TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. Kitchens RL; Thompson PA J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins. Wurfel MM; Wright SD Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933 [TBL] [Abstract][Full Text] [Related]
11. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. Lamping N; Hoess A; Yu B; Park TC; Kirschning CJ; Pfeil D; Reuter D; Wright SD; Herrmann F; Schumann RR J Immunol; 1996 Nov; 157(10):4648-56. PubMed ID: 8906845 [TBL] [Abstract][Full Text] [Related]
12. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235 [TBL] [Abstract][Full Text] [Related]
13. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. Marriott I; Bost KL; Huet-Hudson YM J Reprod Immunol; 2006 Aug; 71(1):12-27. PubMed ID: 16574244 [TBL] [Abstract][Full Text] [Related]
14. LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Branger J; Florquin S; Knapp S; Leemans JC; Pater JM; Speelman P; Golenbock DT; van der Poll T Int Immunol; 2004 Nov; 16(11):1605-11. PubMed ID: 15452020 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide-binding protein accelerates and augments Escherichia coli phagocytosis by alveolar macrophages. Klein RD; Su GL; Schmidt C; Aminlari A; Steinstraesser L; Alarcon WH; Zhang HY; Wang SC J Surg Res; 2000 Dec; 94(2):159-66. PubMed ID: 11104656 [TBL] [Abstract][Full Text] [Related]
16. Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis. Wang SC; Klein RD; Wahl WL; Alarcon WH; Garg RJ; Remick DG; Su GL J Surg Res; 1998 Apr; 76(1):67-73. PubMed ID: 9695742 [TBL] [Abstract][Full Text] [Related]
17. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. Lee JW; Paape MJ; Zhao X Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240 [TBL] [Abstract][Full Text] [Related]
18. A new model of macrophage stimulation by bacterial lipopolysaccharide. Ulevitch RJ; Mathison JC; Schumann RR; Tobias PS J Trauma; 1990 Dec; 30(12 Suppl):S189-92. PubMed ID: 2254981 [TBL] [Abstract][Full Text] [Related]
19. LPS binding protein does not participate in the pharmacokinetics of E5564. Kaneko K; Ueda R; Kawata T; Ishizaka S; Yoshimura T J Endotoxin Res; 2004; 10(3):185-94. PubMed ID: 15198853 [TBL] [Abstract][Full Text] [Related]
20. Altered Kupffer cell function in biliary obstruction. Minter RM; Fan MH; Sun J; Niederbichler A; Ipaktchi K; Arbabi S; Hemmila MR; Remick DG; Wang SC; Su GL Surgery; 2005 Aug; 138(2):236-45. PubMed ID: 16153432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]